'Silymarin' a Potential Treatment Targeting Hepatic Fibrosis of Schistosomiasis

References (41)

1. 1 A Colorimetric Method for the Determination of Serum Glutamic Oxalacetic and Glutamic Pyruvic Transaminases [DOI]
2. 2 The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid [DOI]
3. 3 Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa [DOI]
4. 4 Theory and Practice of Histological Techniques [DOI]
5. 5 Silymarin as a Natural Antioxidant: An Overview of the Current Evidence and Perspectives [DOI]
6. 6 Silybin and Silymarin - New and Emerging Applications in Medicine [DOI]
7. 7 Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years [DOI]
8. 8 Schistosome Infection of Transgenic Mice Defines Distinct and Contrasting Pathogenic Roles for IL-4 and IL-13: IL-13 Is a Profibrotic Agent [DOI]
9. 9 Silybin and the liver: From basic research to clinical practice [DOI]
10. 10 Praziquantel [DOI]
11. 11 Conditions affecting the accuracy of potassium hydroxide digestion techniques for counting Schistosoma mansoni eggs in tissues.
12. 12 Silymarin modulates the oxidant–antioxidant imbalance during diethylnitrosamine induced oxidative stress in rats [DOI]
13. 13 Silymarin in the Prevention and Treatment of Liver Diseases and Primary Liver Cancer [DOI]
14. 14 Protective effect of curcumin on experimentally induced inflammation, hepatotoxicity and cardiotoxicity in rats: Evidence of its antioxidant property [DOI]
15. 15 Schistosome-Induced Fibrotic Disease: The Role of Hepatic Stellate Cells [DOI]
16. 16 Anti-inflammatory/anti-fibrotic effects of the hepatoprotective silymarin and the schistosomicide praziquantel against Schistosoma mansoni-induced liver fibrosis [DOI]
17. 17 Host Regulators of Liver Fibrosis During Human Schistosomiasis [DOI]
18. 18 Pathological lesions associated with schistosoma mansoni infection in man [DOI]
19. 19 A Multicentre Randomized Controlled Trial of the Efficacy and Safety of Single-Dose Praziquantel at 40 mg/kg vs. 60 mg/kg for Treating Intestinal Schistosomiasis in the Philippines, Mauritania, Tanzania and Brazil [DOI]
20. 20 Bioavailability of silymarin flavonolignans: drug formulations and biotransformation [DOI]
21. 21 Silymarin's Protective Effects and Possible Mechanisms on Alcoholic Fatty Liver for Rats [DOI]
22. 22 Combination of Sitagliptin and Silymarin ameliorates liver fibrosis induced by carbon tetrachloride in rats [DOI]
23. 23 Ziziphus spina-christi leaf extract ameliorates schistosomiasis liver granuloma, fibrosis, and oxidative stress through downregulation of fibrinogenic signaling in mice [DOI]
24. 24 Silibinin induces hepatic stellate cell cycle arrest via enhancing p53/p27 and inhibiting Akt downstream signaling protein expression [DOI]
25. 25 Lisinopril inhibits nuclear transcription factor kappa B and augments sensitivity to silymarin in experimental liver fibrosis [DOI]
26. 26 Efficiency of ginger (Zingbar officinale) against Schistosoma mansoni infection during host–parasite association [DOI]
27. 27 Silymarin treatment reduces granuloma and hepatic fibrosis in experimental schistosomiasis [DOI]
28. 28 Therapeutic potential effect of bone marrow-derived mesenchymal stem cells on chronic liver disease in murine Schistosomiasis Mansoni [DOI]
29. 29 Silymarin Reduces Profibrogenic Cytokines and Reverses Hepatic Fibrosis in Chronic Murine Schistosomiasis [DOI]
30. 30 Murine schistosomiasis as a model for human schistosomiasis mansoni: similarities and discrepancies [DOI]
31. 31 Schistosomiasis and hepatic fibrosis regression [DOI]
32. 32 Influence of some micronutrients and Citharexylum quadrangular extract against liver fibrosis in Schistosoma mansoni infected mice [DOI]
33. 33 Deleterious effects of silymarin on the expression of genes controlling endothelial nitric oxide synthase activity in carbon tetrachloride-treated rat livers [DOI]
34. 34 Artichoke leaf extract protects liver of Schistosoma mansoni infected mice through modulation of hepatic stellate cells recruitment [DOI]
35. 35 Basic Clinical Parasitology [DOI]
36. 36 Treatment with milk thistle extract (Silybum marianum), ursodeoxycholic acid, or their combination attenuates cholestatic liver injury in rats: Role of the hepatic stem cells [DOI]
37. 37 Hepatosplenic morbidity due to Schistosoma mansoni in schoolchildren on Ukerewe Island, Tanzania [DOI]
38. 38 Effects and mechanism of action of immunomodulating agents against schistosomiasis-induced hepatic inflammation and fibrosis in mice [DOI]
39. 39 Therapy with bone marrow cells reduces liver alterations in mice chronically infected by Schistosoma mansoni [DOI]
40. 40 Studies on the effect of antioxidant Selenium-ACE after treatment with Praziquantel and Mirazid in Schistosoma mansoni infected mice [DOI]
41. 41 Effect of Curcumin on Hematological, Biochemical and Antioxidants Parameters in Schistosoma Mansoni Infected Mice

Cited by 0

No indexed citations yet.

Related research

• Prevalence of Schistosomia haematobium and Staphylococcus aureus among Pregnant Women in Akure — shares topic coverage
• Lipid Profile in School Children Infected with Urinary Schistosomiasis in Fante Akura-Yeji, Ghana — shares topic coverage
• Prevalence of Schistosomiasis among Primary School Children in Gadabuke District, Toto LGA, North Central Nigeria — shares topic coverage
• Environmental and Behavioral Determinants of Schistosomiasis in Bodo Community, Rivers State, Nigeria — shares topic coverage
• Hidden Burden: Schistosomiasis Prevalence and Risk Factors among Enrolled and Out-of-School Children in Kebbi State, Nigeria — shares topic coverage